Introduction

Salivary gland pathology encompasses a diverse range of conditions including obstructive disorders, inflammatory diseases, infectious processes, and neoplasms. While many conditions resolve with conservative management, surgical intervention becomes necessary for recurrent infections, symptomatic obstruction, malignant neoplasms, and complications refractory to medical therapy. This comprehensive review addresses the clinical evaluation, diagnostic modalities, and surgical management principles for salivary gland disease.

Sialolithiasis: Diagnosis and Treatment

Pathophysiology and Etiology

Sialoliths (salivary stones) form when salivary minerals precipitate around an organic core, typically developing in the main ducts of major salivary glands. The submandibular gland accounts for approximately 80-90% of all sialoliths, with parotid gland involvement in 10-20% of cases. This anatomical distribution reflects several factors: submandibular saliva contains higher mucin and mineral concentrations, the wharton's duct (submandibular duct) has a more tortuous course with narrowing at the orifice, and submandibular saliva is more alkaline with higher calcium and phosphate concentrations.

Risk factors include salivary stasis from reduced flow, dehydration, elevated pH, trauma to the duct system, and systemic diseases affecting salivary composition including gout and hyperparathyroidism. SjΓΆgren's syndrome and autoimmune conditions predispose to stone formation through altered salivary composition and reduced flow rates.

Clinical Presentation

Acute sialolithiasis typically presents with sudden onset of pain and swelling in the affected gland region, particularly with eating. Symptoms worsen during meals when salivary flow increases and pressure builds against the obstructing stone. Between meals, symptoms gradually subside as residual saliva drains around the stone. Intraoral examination may reveal pus expression from the affected duct upon digital pressure over the gland, indicating secondary bacterial infection.

Chronic sialolithiasis may present with recurrent infections, gradual gland enlargement, and formation of secondary stones. Some patients experience minimal symptoms and discover stones incidentally on imaging obtained for other indications.

Diagnostic Imaging

Occlusal radiographs and panoramic radiography visualize radiopaque stones in the submandibular gland duct system with good sensitivity. Approximately 80% of submandibular stones are radiopaque due to mineral content. Parotid stones are less frequently radiopaque (30-40% sensitivity on conventional radiography) due to lower mineral content.

Sialography, the injection of radiographic contrast into the duct system, demonstrates ductal obstruction, stone location, and associated ductal dilatation. Stones appear as radiolucent defects within the opacified duct. This technique provides excellent anatomical detail but has been largely supplanted by cross-sectional imaging and sialoendoscopy.

Ultrasound effectively visualizes stones as echogenic foci with acoustic shadowing. High-resolution ultrasound achieves sensitivity exceeding 95% for stone detection and provides information regarding gland tissue quality and associated inflammation.

Computed tomography and magnetic resonance imaging provide excellent soft tissue and stone visualization, identifying parenchymal changes, chronic inflammation, and complications including fistula formation.

Conservative Management

Acute sialolithiasis management begins with conservative measures. Salivary stimulation through sialagogues (lemon drops, sugar-free gum) increases salivary flow and may facilitate spontaneous stone passage for small stones. Warm compresses applied to the affected gland region provide symptomatic relief. Hydration optimization ensures adequate salivary flow. If secondary bacterial infection is suspected, antibiotics targeting oral flora (amoxicillin-clavulanic acid or clindamycin) are indicated.

Many patients experience symptom resolution during the acute phase, though recurrent episodes are common if the stone remains in place.

Surgical Management

Sialolithotomy (surgical removal of the stone) is indicated for large stones unlikely to pass spontaneously, chronic recurrent symptoms, or associated severe ductal damage. Submandibular sialolithotomy typically utilizes an intraoral approach with incision directly over the stone site in the floor of the mouth. The duct is then carefully incised longitudinally, the stone is extracted, and the duct is either left open to heal secondarily or closed with absorbable sutures to promote epithelialization.

Large parotid stones may be managed through careful intraoral incision over the stone or through external parotid approach with facial nerve identification and preservation. Minimally invasive approaches including transcutaneous removal through small external incisions have gained popularity for accessible stones, particularly those near the gland hilum.

Submandibular gland excision (sialolithotomy with sialadenectomy) becomes necessary when chronic inflammatory changes have destroyed significant parenchymal function, recurrent obstruction occurs despite previous stone removal, or significant purulent secretion indicates chronic infection. This procedure requires careful attention to protecting the lingual and hypoglossal nerves, which course in proximity to the gland.

Sialoendoscopic Management

Sialoendoscopy represents a minimally invasive alternative for stone management, utilizing rigid or semi-flexible endoscopes introduced into the salivary duct system. Stones can often be visualized directly, fractured using ultrasonic or laser energy, and extracted under direct visualization. Success rates for stone fragmentation and removal exceed 80% for accessible stones.

Advantages of sialoendoscopy include preservation of salivary gland function, minimal tissue trauma, and rapid recovery compared to formal sialolithotomy. Limitations include difficulty managing very large stones, inability to access intraglandular stone locations, and risk of ductal perforation in cases of severe stricture disease. Appropriate patient selection is essential for optimal outcomes.

Salivary Gland Neoplasms

Epidemiology and Classification

Salivary gland tumors represent 3-6% of head and neck neoplasms. The parotid gland is the most frequently involved site (70-80% of salivary tumors), followed by submandibular gland (10-20%), and minor salivary glands (5-10%). Approximately 80% of parotid tumors are benign, compared to only 50% of submandibular tumors and 40% of minor salivary gland tumors. This distribution reflects different biological potential based on anatomical location and histological type.

Benign neoplasms include pleomorphic adenoma (mixed tumor), accounting for 60% of parotid tumors, and Warthin tumor (papillary cystadenoma lymphomatosum), representing 10-15% of parotid tumors. Malignant tumors include adenoid cystic carcinoma, mucoepidermoid carcinoma, acinic cell carcinoma, and carcinoma ex pleomorphic adenoma.

Diagnostic Approach

Clinical evaluation begins with careful palpation to assess size, consistency, fixation to surrounding tissues, and mobility. Mobile, well-circumscribed tumors suggest benign pathology, while fixed masses, skin involvement, or facial nerve involvement raise concern for malignancy.

Fine-needle aspiration cytology (FNAC) provides tissue diagnosis with minimal morbidity. Imaging including ultrasound and magnetic resonance imaging characterizes tumor size, location, relationship to vital structures, and perineural spread patterns.

Parotidectomy Procedures

Benign parotid tumors are typically managed with superficial parotidectomy (lateral parotidectomy), removing the portion of the gland lateral to the facial nerve. This approach allows complete tumor removal while preserving the facial nerve and associated sensory function. The procedure begins with a preauricular or modified Blair incision, dissection of skin flaps to expose the parotid capsule, identification of the facial nerve trunk at the stylomastoid foramen, and careful dissection of the facial nerve branches.

Conservative parotidectomy (limited parotidectomy) removes only the tumor and surrounding gland tissue with minimal facial nerve dissection, appropriate for small, well-circumscribed benign tumors located away from the nerve. Extracapsular dissection (parotidectomy-sparing approach) removes the tumor with a small cuff of surrounding gland parenchyma, minimizing trauma and preserving maximum gland function.

Total parotidectomy becomes necessary for malignant tumors with extension across the facial nerve plane or for large benign tumors requiring complete removal. This procedure involves complete facial nerve dissection and removal of all parotid tissue.

Facial Nerve Preservation

Facial nerve preservation represents a critical surgical principle, as postoperative facial nerve dysfunction significantly impacts patient quality of life. Intraoperative monitoring using electromyography provides real-time feedback regarding nerve function, allowing surgeons to modify technique if electrical activity decreases. Careful dissection using anatomical landmarks (tragal pointer, posterior belly of digastric muscle, stylomastoid foramen) identifies the nerve trunk without requiring extensive dissection that risks nerve injury.

Immediate postoperative facial nerve function is present in 80-90% of cases following careful dissection without intraoperative nerve injury. Transient weakness occurs in some patients due to nerve stretching, typically resolving within weeks to months. Permanent facial nerve dysfunction occurs in less than 2% of cases when parotidectomy is performed by experienced surgeons, though this rate increases with malignant tumors requiring formal nerve dissection and potential sacrifice.

Submandibular Gland Management

Submandibular gland tumors, more frequently malignant than parotid tumors, typically require surgical excision. Benign tumors may be managed with intraoral enucleation when feasible, though external approach provides better visualization and control. Malignant tumors require formal submandibular gland excision with careful attention to protecting the lingual and hypoglossal nerves.

The procedure involves either intraoral incision in the floor of mouth or external cervical approach, dissection of the gland from surrounding tissues including removal of associated lymph nodes, careful nerve identification and preservation, and specimen extraction. Perioperative morbidity includes temporary tongue weakness from hypoglossal nerve stretching, hypoesthesia from lingual nerve injury, and rare permanent neurological dysfunction.

Post-Surgical Complications and Management

Immediate Complications

Hemorrhage and seroma formation occur when vessels within or adjacent to salivary glands are incompletely hemostasis. Careful intraoperative hemostasis, placement of drains, and pressure dressings minimize these complications. Temporary facial nerve weakness from stretching (neurapraxia) occurs frequently but typically resolves spontaneously within weeks. Persistent weakness suggests nerve injury and may require further evaluation and management.

Long-Term Complications

Frey's syndrome (gustatory sweating) represents aberrant reinnervation of sweat glands in the region of the surgical site, causing facial sweating with eating. This occurs in up to 50% of patients following parotidectomy but frequently improves with time. Botulinum toxin injections provide effective symptom management by blocking acetylcholine release to sweat glands.

Greater auricular nerve injury causes numbness of the ear lobe and surrounding skin, occurring in up to 50% of parotidectomy cases but frequently improving over months. Careful nerve identification and preservation minimize this morbidity.

Salivary fistula formation occurs when residual salivary tissue produces saliva that drains externally rather than through normal ducts. This usually resolves spontaneously but may require revision surgery if persistent beyond 3-6 months.

Conclusion

Salivary gland surgery requires comprehensive understanding of gland anatomy, pathophysiology of various conditions, and appropriate patient selection for conservative versus surgical management. Modern approaches emphasizing minimally invasive techniques, particularly sialoendoscopy for obstructive disease, combined with meticulous surgical technique for neoplasm resection, optimize functional outcomes while managing pathology effectively.